Cigna's decision to pull out of Affordable Care Act individual marketplaces in 2027 has raised many questions. The insurer cited limited growth potential and a strategic shift toward more profitable divisions. Below, we break down the key details, including timing, member impact, and what comes next.

Why is Cigna leaving the ACA individual marketplaces?

Cigna announced on its first-quarter earnings call that it will withdraw from Affordable Care Act individual exchanges by 2027. Chief Operating Officer Brian Evanko explained that the decision was driven by two main factors. First, the company saw no viable path to significantly grow its ACA membership, which stood at 369,000 across 11 states. Second, exiting allows Cigna to reallocate resources toward more promising areas like its Evernorth specialty and care services, pharmacy benefits management, and employer-based insurance plans. The move wasn't taken lightly, but executives believe it positions the company for better long-term returns. Find out how many members are affected.

When exactly will Cigna exit, and how many members are affected?

Cigna will leave the ACA individual markets in 2027. As of the first quarter of 2025, the insurer had 369,000 ACA members across 11 states. While that number seems large, it represents a tiny fraction of Cigna's total 18.3 million members. The affected individuals will need to find new coverage for 2027, either through other insurers on the exchanges, employer-sponsored plans, or other options. Cigna has not yet detailed transition assistance, but such moves typically include informing members well in advance and helping them navigate alternatives.

What does "meaningful growth" mean in Cigna's decision?

Executives specifically stated they could not see a way to "meaningfully grow" the ACA individual business. This likely reflects the volatility of the individual market, where member churn is high, premium regulations are tight, and margins are thin. Meanwhile, other segments like employer group plans and pharmacy benefits offer steadier revenue streams and higher profitability. By stepping away, Cigna avoids investing capital and resources into a market with uncertain returns, freeing them to double down on areas where they already hold strong competitive advantages.

Which business areas will Cigna focus on instead?

Cigna plans to redirect attention to its Evernorth division, which provides specialty pharmacy and care coordination services; its pharmacy benefits manager (PBM); and its employer-sponsored insurance plans. These segments have demonstrated consistent growth and higher margins. Evernorth, in particular, has become a core profit driver, offering services like specialty drug management and behavioral health. The employer business remains Cigna's largest block, serving millions of workers and their families. By consolidating around these strengths, Cigna aims to improve efficiency and long-term financial performance.

How did the financial results factor into this announcement?

The ACA exit was disclosed during Cigna's first-quarter earnings call, where the company reported $1.7 billion in profit and raised its full-year earnings forecast. These better-than-expected results likely gave executives confidence to execute the strategic shift. Investors had already anticipated some streamlining after Cigna's failed merger with Humana. The exit aligns with a broader industry trend of insurers reassessing their ACA participation, with several major players reducing exposure in recent years. The strong financial footing means Cigna can absorb transition costs without major disruption.

What does this mean for patients currently in Cigna ACA plans?

Current Cigna ACA members will need to enroll in new plans at the end of 2026 for coverage starting in 2027. They can choose other insurers on their state's exchange, or if eligible, transition to employer coverage or public programs like Medicaid. While this creates short-term uncertainty, the ACA market is designed to promote competition and choice. Cigna will likely send detailed notices and may work with regulators to ensure a smooth transition. Patients should watch for communications starting in late 2026 and consider exploring options during the open enrollment period.